Cargando…

COVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants

The coronavirus disease 2019 (COVID-19) pandemic is one of the most consequential global health crises in over a century. Since its discovery in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to mutate into different variants and sublineages, rendering previously potent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Padasas, Bill Thaddeus, Españo, Erica, Kim, Sang-Hyun, Song, Youngcheon, Lee, Chong-Kil, Kim, Jeong-Ki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Immunologists 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166656/ https://www.ncbi.nlm.nih.gov/pubmed/37179752 http://dx.doi.org/10.4110/in.2023.23.e13

Ejemplares similares

Surveillance of avian influenza viruses from 2014 to 2018 in South Korea
por: Españo, Erica, et al.
Publicado: (2023)

Lipophilic statins inhibit Zika virus production in Vero cells
por: Españo, Erica, et al.
Publicado: (2019)

Effects of Statin Combinations on Zika Virus Infection in Vero Cells
por: Españo, Erica, et al.
Publicado: (2022)

Inhibitory effects of aprotinin on influenza A and B viruses in vitro and in vivo
por: Song, Eun-Jung, et al.
Publicado: (2021)

Utilization of Aloe Compounds in Combatting Viral Diseases
por: Españo, Erica, et al.
Publicado: (2022)

Adjuvanticity of Processed Aloe vera gel for Influenza Vaccination in Mice
por: Song, Eun-Jung, et al.
Publicado: (2020)

Phytochemicals for the treatment of COVID-19
por: Españo, Erica, et al.
Publicado: (2021)

Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant
por: Ryu, Dong-Kyun, et al.
Publicado: (2021)

COVID-19 Antiviral and Treatment Candidates: Current Status
por: Españo, Erica, et al.
Publicado: (2021)

Therapeutic applications of nanobodies against SARS-CoV-2 and other viral infections: Current update
por: Bhattacharya, Manojit, et al.
Publicado: (2023)

Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia
por: Kim, Jiyeon, et al.
Publicado: (2019)

A Novel Bacterium, Butyricimonas virosa, Preventing HFD-Induced Diabetes and Metabolic Disorders in Mice via GLP-1 Receptor
por: Lee, Heetae, et al.
Publicado: (2022)

Surveillance of avian influenza viruses from 2009 to 2013 in South Korea
por: Nam, Jeong-Hyun, et al.
Publicado: (2021)

Incidence Evaluation of SARS-CoV-2 Variants in the Ulsan Area, Korea, Using PowerChek SARS-CoV-2 S-gene Mutation Detection Kit: A Pilot Study
por: Park, Sang Hyuk, et al.
Publicado: (2022)

Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
por: Zhang, Na-Na, et al.
Publicado: (2022)

Updated Approaches against SARS-CoV-2
por: Li, Haiou, et al.
Publicado: (2020)

An Update on Detection Technologies for SARS-CoV-2 Variants of Concern
por: Jiang, Wenjie, et al.
Publicado: (2022)

Massively multiplexed affinity characterization of therapeutic antibodies against SARS-CoV-2 variants
por: Engelhart, Emily, et al.
Publicado: (2022)

Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome
por: Shin, Chong-Hyun, et al.
Publicado: (2021)

Immunogenicity after outbreak response immunization activities among young healthcare workers with secondary vaccine failure during the measles epidemic in Korea, 2019
por: Seok, Hyeri, et al.
Publicado: (2022)

Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants
por: Ko, Hae Li, et al.
Publicado: (2023)

Downregulation of IL-18 Expression in the Gut by Metformin-induced Gut Microbiota Modulation
por: Lee, Heetae, et al.
Publicado: (2019)

High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern
por: Moreira-Soto, Andres, et al.
Publicado: (2021)

Potential Therapeutic Approach of Melatonin against Omicron and Some Other Variants of SARS-CoV-2
por: Begum, Rahima, et al.
Publicado: (2022)

SARS-CoV-2 mRNA Vaccine Elicits Sustained T Cell Responses Against the Omicron Variant in Adolescents
por: Choi, Sujin, et al.
Publicado: (2023)

Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review
por: Jeong, Gi Uk, et al.
Publicado: (2020)

Transmissibility and pathogenicity of SARS-CoV-2 variants in animal models
por: Kim, Young-Il, et al.
Publicado: (2022)

Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections
por: Kim, Byoung-Jun, et al.
Publicado: (2021)

A novel bispecific antibody dual-targeting approach for enhanced neutralization against fast-evolving SARS-CoV-2 variants
por: Kim, Ji Woong, et al.
Publicado: (2023)

Potential Therapeutic Effect of Micrornas in Extracellular Vesicles from Mesenchymal Stem Cells against SARS-CoV-2
por: Park, Jae Hyun, et al.
Publicado: (2021)

Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus
por: Omolo, Calvin A., et al.
Publicado: (2020)

Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection
por: Jeong, Hye Won, et al.
Publicado: (2022)

Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021
por: Kim, Eun-Young, et al.
Publicado: (2022)

Microalgae as an Efficient Vehicle for the Production and Targeted Delivery of Therapeutic Glycoproteins against SARS-CoV-2 Variants
por: Dehghani, Jaber, et al.
Publicado: (2022)

An Update on mRNA-Based Viral Vaccines
por: Jeeva, Subbiah, et al.
Publicado: (2021)

SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021
por: Alkhatib, Mohammad, et al.
Publicado: (2021)

An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines
por: Hillary, Varghese Edwin, et al.
Publicado: (2023)

Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
por: Firouzabadi, Negar, et al.
Publicado: (2023)

MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants
por: Lee, Sua, et al.
Publicado: (2021)

The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2
por: Ryu, Dong-Kyun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4div9ia3s15gqbc87fhr7gop8j